Objective-Cardiac progenitor cells reside in the heart in adulthood, although their physiological relevance remains unknown.
C ardiovascular disease is the main cause of morbidity and mortality in the developed world; acute myocardial infarction (AMI), the most prominent cardiac disease in adults, affects millions of people. 1 During AMI, mechanical and chemical stress induce massive loss of cardiomyocytes and cardiac vasculature, followed by a critical revascularization process and formation of a fibrotic scar. 2 After damage, organized ventricular remodeling is the major determinant of long-term survival. 3 To preserve cardiac function after AMI, the mammalian heart develops a hypertrophic response. In some cases, damage evolves to ischemic-dilated phenotype characterized by left ventricular (LV) enlargement, that tends to progress to systolic dysfunction and end-stage disease. 4 Despite intensive research to identify genetic mutations involved in the development of inherited cardiomyopathies, 5 only a few studies have focused on the relevance of endogenous adult cell populations in AMI evolution. 6, 7 See cover image Adult cardiac progenitor cells and proliferation of mature cardiac cells are reported to contribute to murine cardiac cell turnover. 8, 9 Cardiac progenitor cells were described >10 years ago based on c-kit expression. 10 Since then, several adult cardiac progenitor cells have been proposed based on membrane markers (Sca1 [stem cell antigen-1 (Ly-6A/E)], 11 Abcg2 [ATP-binding cassette transporter G2], 12 Myh6 [myosin heavy chain 6], 13 and PDGFRα [platelet-derived growth factor receptor-α] 14 ) or transcription factors (Isl1 [ISL LIM homeobox 1], 15 Gli1 [gliomaassociated oncogene homolog 1], 6 and Bmi1 16 ), although their contribution to de novo cardiac cell turnover is relatively slow in homeostasis. These cardiac progenitor subsets might represent transient physiological states of a single cell population.
The importance of these adult cardiac cell populations was nonetheless always based on lineage tracing experiments. 17 In contrast to other organs such as intestine, 18 bone marrow (BM), 19 and lung, 20 the physiological relevance of cardiac progenitor cells has not been demonstrated functionally by their elimination from the adult heart. Only Gli1 + fibroblast progenitor cells have been described as detrimental in ventricular remodeling after AMI. 6 We previously identified that Bmi1 is preferentially expressed by a subpopulation of
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Sca1 + cardiac progenitor cells in murine adult heart (≈5% of Sca1 + cells), and Sca1 + Bmi1 + cells are able to differentiate to the 3 main cardiac lineages. 16 The physiological relevance of these progenitor cells nonetheless remains undefined. Here, our results indicate that Sca1 +
Bmi1
+ cardiac cells (hereafter Bmi1 + cells) have a mainly endothelial-related phenotype and contribute markedly to de novo cardiac vasculature in post-AMI revascularization. Resident Bmi1 + cardiac progenitor cells are necessary for natural ventricular remodeling after AMI; their depletion induces a deficient angiogenic response and increased scar size, leading to an ischemic-dilated cardiac phenotype in mice.
Materials and Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Transgenic Mice and Tamoxifen Administration

Transgenic mice were Bmi1
CreERT/+ , 21 Bmi1 GFP/+ , 22 Rosa26 DTA/+ , 23 
Rosa26
YFP/+ , Rosa26 Tomato/+ (Ai9), and β-actin GFP/+ (all from Jackson Laboratory), all on the C57BL/6 background. The full description of transgenic mouse lines and their application in this study can be consulted in Table I in the online-only Data Supplement. Tamoxifen (Tx) was dissolved in corn oil (Sigma); mice received Tx (IP) every 24 hours for 3 consecutive days (225 μg/g body weight daily), or once (7.5 μg/g body weight) for low Tx induction. Because preliminary analysis showed no differences between male and female mice, all experiments were performed in males and females, as recommended by the US National Institutes of Health. 24 Animal studies were approved by the CNB- 
AMI and 5-Fluorouracil Treatment
Mice were anesthetized with 4% sevoflurane, intubated, and ventilated with a 50% air:oxygen mixture using a positive-pressure respirator (Minivent 845, Harvard; 160 strokes/min, 250 μL tidal volume). A left thoracotomy was performed via the fourth intercostal space, and the lungs retracted to expose the heart. After opening the pericardium, we ligated the left anterior descending coronary artery with 7-0 silk suture ≈2 mm below the edge of the left atrial appendage. Ligation was considered successful when the anterior wall of the LV became pale. The lungs were inflated by increasing positive end-expiratory pressure, and the thoracotomy site closed in layers with 6-0 suture. Mice were maintained on a 37°C heating pad until recovery and for 2 hours after surgery. Another group of mice underwent sham ligation, with a similar surgical procedure without tightening the suture around the coronary artery.
To induce BM aplasia, 5-fluorouracil (50 mg/kg body weight; Sigma) was administered (intravenously), and hearts were infarcted 4 days after drug treatment.
Human Heart Samples
Human cardiac biopsies were obtained from patients who underwent open-chest surgery, usually for valve replacement. Starting material was obtained from the right atrium appendage, which is routinely removed to place the cannula for extracorporeal circulation. Tissue samples were minced (<1 mm 3 pieces) and treated with collagenase type 2 (Worthington Biochemical; 3 cycles, 30 minutes each) to obtain a cell suspension. Cardiomyocytes were removed by centrifugation and filtration using 40 μm cell strainers. Human c-Kit + and c-Kit − nonmyocyte cells were purified from 3 human myocardial samples by CD45 depletion, followed by c-Kit immunoselection as described, 25 and expanded for 2 passages for characterization. 
Echocardiography
Mice were anesthetized by isoflurane:oxygen inhalation (1.25:98.75%), and echocardiography performed with a 30-MHz transthoracic echocardiography probe. Images were obtained with the Vevo 2100 micro-ultrasound imaging system (VisualSonics, Toronto, Canada). Measurements of left parasternal long and short axes and M-mode images (left parasternal short axis) were obtained at a heart rate of 500 to 550 bpm. LV end-diastolic diameter (LVEDD), LV endsystolic diameter (LVESD), and wall thickness were measured from M-mode tracings, and the mean of 3 consecutive cardiac cycles is reported. The LV fractional shortening percentage was calculated as ([LVEDD−LVESD]/LVEDD)×100. For image acquisition, we used a combination of volume coil/surface coil to enhance signal-to-noise ratio formed by a 72-mm inner diameter quadrature birdcage TX coil (Rapid Biomedical, Rimpar, Germany) and an actively detuning 30-mm flexible customized surface RX coil (Neos Biotec, Pamplona, Spain). After a tripilot gradient-echo image, a gradient-echo sequence without gating was used to acquire oblique coronal and axial slices. From these images, we determined interventricular septum, LV posterior wall thicknesses, and LV corrected mass; the short-axis M-mode quantification was chosen as most representative. Function was estimated from the ejection fraction and fractional shortening obtained from M-mode views. All procedures were performed blind by 2 echocardiography experts. For ejection fraction measurements, a long-or short-axis view of the heart was selected to obtain an M-mode registration in a line perpendicular to the LV septum and posterior wall at the level of the mitral chordae tendineae. For echocardiographic analysis of infarct size 5 days after infarction, regional LV function was evaluated in the parasternal long-axis view. The LV wall was subdivided into 13 segments (basal, mid, and apical from the anterior, posterior, lateral and septal walls, as well as the apex). Each segment was scored in a blind manner by an independent evaluator, based on motion and systolic thickening, according to American Society of Echocardiography guidelines (1, normal or hyperkinetic; 2, hypokinetic; 3, akinetic, negligible thickening; 4, dyskinetic, paradoxical systolic motion; and 5, aneurysmal, diastolic deformation). 27 The number of dysfunctional segments was quantified, and the total score representing the sum of the score of the 13 individual segments was calculated for each heart. 28 At 5 days after 
Histology and Immunohistochemical Analyses
For histological analysis, hearts and small intestines were fixed in 4% paraformaldehyde (PFA; overnight, 4°C), dehydrated and paraffinembedded for preparation of 10-μm histological sections. Rehydrated slides were stained with Masson trichrome. For immunohistochemistry, hearts and small intestines were fixed in 4% PFA as above and cryopreserved in 30% saccharose, frozen in optimal cutting temperature compound, and sectioned in 8-μm sections on a cryostat. Heart immunohistochemistry and immunocytochemistry have been described. 16 Primary antibodies are shown in Table II in the onlineonly Data Supplement. A TUNEL assay kit (Roche) was used for histochemical detection of apoptotic cells in heart sections. For histological quantification, at least 30 representative transverse heart or small intestine sections from ventricles and atria were used. Surface areas were quantified by acquiring random images (200×) and calculating the number of stained surfaces per total surface, using ImageJ software (US National Institutes of Health). For Bmi1 + cell detection at 5-day postlow Tx induction, we measured the number and distance of Bmi1 + cells in 2 ventricular serial histological areas (8 μm×40 sections) in upper and lower ventricle parts (n=3); we defined a groups of cells as located within a 100 μm radius, considering each histological area as a 3-dimensional structure. Images were captured with a Zeiss LSM 700 or Leica TCS SP5 with fixed settings based on negative controls (isotype controls). Processing, including pseudocolor assignment and changes in brightness, was applied uniformly to the entire image to equalize the appearance of multiple panels in a single figure.
Adult Cardiomyocyte and Nonmyocyte Cell Isolation and Cell Culture
Nonmyocyte cells and cardiomyocytes were obtained by the Langendorff method using retrograde perfusion through the aorta. The heart was removed rapidly and retrograde-perfused under constant pressure (60 mm Hg; 37°C, 8 minutes) in Ca . When the heart became swollen (10 minutes), it was removed and gently teased into small pieces with fine forceps in the enzyme solution. Heart tissue was further dissociated mechanically using 2, 1.5, and 1 mm-diameter pipettes until all large tissue pieces were dispersed. The digestion buffer was neutralized with stopping buffer (10% fetal bovine serum [FBS], 12.5 μmol\L CaCl 2 ). Cardiomyocytes were pelleted by gravity (7×, 30 minutes each), the supernatant contains nonmyocyte cardiac cells.
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BM Cell Populations
For BM cell analyses, femurs were removed from mice and BM extracted by complete flushing with PBS in sterile conditions. BM populations were defined as hematopoietic progenitors (CD34 
In Vitro Cell Culture
Matrigel Tube Formation Assay
Matrigel tube formation assay was developed and quantified as detailed.
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Cumulative Population Doubling
Cells were passaged as they reached 80% confluence. Cumulative population doubling at each passage was calculated from the cell count with the equation N H /N 1 =2
x , where N 1 is inoculum number, N H is cell harvest number, and X is population doublings. The population doublings were added to yield cumulative population doubling. Replicative senescence is defined as X<1 for 2 weeks.
Flow Cytometry
For flow cytometry analysis, hearts were digested by the Langendorff method and nonmyocyte-enriched fractions analyzed with a Beckman Coulter Moflow XDP cell sorter, and Beckman Coulter GALLIOS Analyzer and BD FACSCanto II cytometers. FlowJo vX1 (TreeStar) software was used for data analysis.
Western Blot
For Western blot, cells and tissues were lysed (45 minutes, 4°C) in radioimmunoprecipitation assay buffer (RIPA; Sigma-Aldrich), with the addition of cOmplete, EDTA-free Protease Inhibitor Cocktail (Roche). Proteins were quantitated using the Infinite m200 (Tecan). Lysates were size-fractionated by SDS-PAGE, transferred to Hybond ECL nitrocellulose membranes (GE Healthcare), probed with indicated antibodies (Table II in 
Reverse Transcription Quantitative PCR Analysis
RNA was purified using the Cells-to-CT kit (Ambion, Thermo). Complementary DNA was obtained by reverse transcription with the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). cDNAs were analyzed by real-time PCR using the Power SYBR Green PCR Master Mix (Applied Biosystems). Amplification, detection, and data analysis were performed with an ABI PRISM 7900HT Sequence Detection System and normalized to GusB and Gapdh expression. Changes in mRNA expression are noted as x-fold change relative to the control. qPCR primers are listed in Table II in the online-only Data Supplement.
Statistical Analysis
Statistical analyses were performed with GraphPad Prism 6.01. Data were subjected to the Shapiro-Wilk test for normality and F test for equality of variances. For 2 groups, those that passed normality and equal variance tests were analyzed by the Student t test (2-tailed, unpaired) and those that failed normality and equal variance tests were analyzed by nonparametric Mann-Whitney rank-sum test. For multiple groups, data that passed normality and equal variance tests were analyzed by 1-way ANOVA with Tukey post hoc test, and those data that failed normality and equal variance tests were analyzed by the Kruskal-Wallis ANOVA with Dunn multiple comparisons test. To analyze cell distributions, nonparametric 2-sample Kolmogorov-Smirnov test was used. Survival curves were generated by the Kaplan-Meier method and compared using the log-rank test. A value of P<0.05 was considered significant. All replicates considered are biological replicates.
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Results
BMI1 Expression Identifies an Endothelial/ Mesenchymal-Related Population of Nonmyocyte Cells in Adult Mouse Heart
We used Bmi1 GFP/+ knock-in mice 22 to analyze Bmi1 expression in heart compared to constitutive GFP (green fluorescent protein) expression in β-actin GFP/+ mice. Comparative FACS (fluorescence-activated cell sorting) analyses showed that in adult heart, Bmi1 expression was restricted to a subpopulation of nonmyocyte cells ( Figure 1A ). Whereas the fluorescence intensity in GFP + nonmyocyte cells resembled that of constitutive expression, FACS and immunocytochemistry showed no or very low GFP levels in adult cardiomyocytes ( Figure 1B and 1C), as confirmed by reverse transcription quantitative PCR (RT-qPCR; Figure 1D ).
To better define the identity of cardiac Bmi1 + cells, we exhaustively characterized Bmi1
CreERT/+
R26
Tomato/+ adult heart sections 5-day post-Tx induction. Cardiac Bmi1 + cells were negative for the mature endothelial-related surface markers von Willebrand factor and VE-cadherin (CDH5; <2%), although the majority of these cells expressed CD31 (85±3%; Figure 1E ). We also assessed expression of several surface markers reported for adult cardiac progenitor cells. 14, 17, 30 Bmi1 + cells were negative for pericyte-related α-SMA (α-smooth muscle actin), pericyte/endothelial melanoma cell adhesion molecule (CD146), and fibroblast-related markers CD90 and FSP-1. They were also negative for the mesenchymal-related markers nestin and endoglin (CD105) although 12±2% of Bmi1 + cells expressed PDGFRα (PDGFRα; CD140a; Figure 1E ), which is linked to the clonogenic Sca1 + cardiac progenitor subpopulation.
14 FACS characterization of whole digested heart showed that CD31 and PDGFRα features were mutually exclusive in Bmi1 + cells ( Figure 1F ). The data show that Bmi1 expression is linked to a mixture of endothelial-and mesenchymal-related nonmyocyte Sca1 + cells in the adult mouse heart.
Cardiac Bmi1 + Cells Are Not a Subpopulation of Mature Endothelial Cells
Although endothelial surface markers are associated with various adult progenitor cell populations, [31] [32] [33] [34] CD31 has classically been linked to mature endothelial cells. To rule out the possibility that cardiac Bmi1 + cells were a mature endothelial cell subpopulation, we compared them to endothelial (CD31 + ) and mesenchymal (PDGFRα) primary cardiac cells. In the heart, Bmi1 + cells were located in a perivascular position, but never in the tunica intima of blood vessels ( Figure  IA 
Human c-Kit + Cardiac Stem Cells Are Not the Main Source of BMI1 in Human Heart
Although recent studies challenge the identity and the multipotent differentiation capacity of c-Kit + human cardiac progenitor cells, 35, 36 c-Kit + CD45 − cells are the most widely reported human cardiac stem cells. 37 To evaluate whether these cells are the main source of BMI1, we measured its expression in c-Kit ) prompted us to analyze in vivo cell dynamics to identify true differentiation potential. A difference from other organs, the heart lacks a defined, physical niche-like structure; 40 to pinpoint differences in differentiation capacity and in vivo cell dynamics, we therefore adjusted the Tx dose (7.5 μg/g weight; low-dose) to label disperse cells (>200 μm). At 5-day post-Tx low-dose induction in Bmi1
R26
Tomato/+ mice, the majority of Bmi1 + progenitor cells were spaced >200 μm apart (96±3%, n=205 cells, 3 mice), in contrast to the more closely spaced cell distribution after our standard Tx induction ( Figure IIIA 
Tomato/+ hearts confirmed the small percentage of labeled cardiac Bmi1 + cells after low-dose Tx induction (1:1000 Bmi1 + cells; ≈100 Bmi1 + cells/heart; Figure IIIB in the online-only Data Supplement). Bmi1-derived cell group size increased homogeneously in an age-dependent fashion, which suggested that there were no subpopulation-associated differences in cell dynamics (Figure 2A ; Figure IIIC in the online-only Data Supplement).
As for Sca1 + cardiac progenitor cells, 11 there were few groups with the 3 main cardiac cell lineages (endothelial, smooth muscle, and cardiomyocyte), although rare examples were found ( Figure 2B ; Figure IIID in the online-only Data Supplement). Histological analyses at 6 months after low-dose Tx induction showed that groups of Bmi1-derived endothelial or smooth muscle cells were more frequent than cardiomyocyte groups ( Figure 2C ). Labeling was negligible in vehicle-treated mice (one group of 1-3 cells in 2 of 4 mice at 6 months of age). These results suggest that in homeostasis, adult Bmi1 + cardiac cells have a strong in vivo differentiation bias, with limited multilineage potential.
In Vivo Genetic Ablation of Bmi1 + Cardiac Progenitor Cells by Cre-Mediated Expression of Diphtheria Toxin A
To ablate Bmi1 + progenitor cells and evaluate their in vivo relevance in the adult heart, we crossed Tx-inducible Bmi1
CreERT mice with an improved mouse line for Cre-induced cell ablation based on diphtheria toxin A (DTA) expression (R26 DTA ).
23
Bmi1
CreERT/+ R26 DTA/+ adult hearts were phenotypically and functionally identical to R26 DTA/+ control hearts, ruling out nonspecific CRE activity in the absence of Tx ( Figure IVA through IVC in the online-only Data Supplement). To evaluate system ablation efficiency, we generated the triple transgenic Bmi1
CreERT/+ R26 YFP/DTA mouse line ( Figure 3A ). Five days of post-Tx induction, >97% of YFP + cells (2.5±0.4% of total nonmyocyte cells) were eliminated compared with bigenic Bmi1
CreERT/+ R26 YFP/+ control mice ( Figure 3A) . DTA activity was restricted to nonmyocyte cells, as TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) assay ruled out Tx-related apoptosis in cardiomyocytes at 1-and 5-day post-Tx treatment ( Figure IVD in the onlineonly Data Supplement). RT-qPCR and Western blot analyses confirmed significantly reduced BMI1 expression only in the nonmyocyte cell fraction, which indicates successful ablation of Bmi1 + cardiac progenitor cells after Tx induction ( Figure 3B and 3C) . [Tx]) mice were used as controls ( Figure 4A ). Five days post-AMI, echocardiography showed a functional decline in all mice groups regardless of Tx treatment ( Figure 4B ) and confirmed a similar degree of heart dysfunction ( Figure IVE in the online-only 
Elimination of
Data Supplement). Two months after damage, echocardiography detected a reduced LV ejection fraction in Bmi1
CreERT/+ R26 DTA/+ (Tx) hearts compared with controls ( Figure 4B ). This cardiac dysfunction was sustained >2 additional months and affected survival of Bmi1 + cell-deficient mice ( Figure 4C ). At this time, histological analysis of Bmi1 + cell-deficient hearts confirmed differences in cardiac remodeling compared with infarcted controls. The former presented eccentric cardiac hypertrophy (an ischemic-dilated cardiac phenotype) characterized by LV chamber dilatation, thinning of the interseptal wall, and reduced ejection fraction ( Figure 4D and 4E) . We found no differences in LV mass as measured by echocardiography or heart/body weight ratio, although we detected a slight increase in myocyte cross-sectional length in Bmi1 + cell-deficient hearts ( Figure IVF through IVH in the online-only Data Supplement), possibly linked to an increase in hemodynamic pressure associated with the deficient LV remodeling after AMI.
Prognosis and progression of ischemic damage depend on fibrotic and angiogenic responses after AMI. Deficiencies in these processes affect cardiac remodeling and induce cardiac dysfunction. 41, 42 Quantification of fibrosis in histological sections showed no notable differences between groups ( Figure 5A and 5B), although we detected an increase in LV scar size in Bmi1 + cell-deficient hearts ( Figure 5C ). Histological and FACS analyses showed, and RT-qPCR confirmed, that absence of Bmi1 + progenitor cells altered the angiogenic response after AMI; mature endothelium was decreased in scar and in remote infarct areas, particularly in small blood vessels ( Figure 5D through 5G).
Extracardiac Cell Ablation Does Not Affect Cardiac Function
Bmi1 is a marker of various adult stem cell populations, 43 and BM is considered the main organ in crosstalk with the heart. 44 We previously discarded BM origin of Bmi1 + cardiac progenitor cells, 16 but it could be possible that Bmi1-cell ablation affected BM-derived cells (CD45 + ). Tx treatment provoked no differences in the percentage of BM populations but induced a nonsignificant decrease in BM cell numbers ( Figure  VA and VB in the online-only Data Supplement). In the heart, cardiac resident hematopoietic-derived cells (CD45 + ) were also unaffected ( Figure VC and VD in the online-only Data Supplement). To further confirm the lack of a Bmi1-BM cell role in cardiac dysfunction, we used 5-fluorouracil to induce a decrease in BM cell number, similar to the BM cell ablation after Tx induction in bigenic Bmi1 
Bmi1
+ cardiac cells are not essential for cardiac function and that the heart could has compensatory mechanisms to replenish Sca1 +
+ cardiac progenitor cells.
Bmi1 + Cardiac Progenitor Cells Are a Source of Endothelial Cells After AMI
We induced lineage tracing in Bmi1
R26
YFP/+ mice to analyze the real contribution of Bmi1 + progenitor cells to cardiac progeny after AMI. To exclude the possibility that residual Tx induces CRE activity in Bmi1 + cells after injury, hearts were infarcted 2-week post-Tx induction, a period sufficient to ensure its clearance. 46 We also ruled out an AMI-dependent BMI1 upregulation ( Figure VIIG in the online-only Data Supplement). Although we confirmed an increase in Bmi1-derived cardiomyocytes in remote areas at 4 months after AMI 47 ( Figure VIIH in the online-only Data Supplement), histological and FACS analyses highlighted a relatively large proportion of Bmi1-derived nonmyocyte cells ( Figure 6A and 6B). Despite 4 months after damage, we detected a small percentage of cardiac fibroblasts derived from Bmi1 + progenitor cells (<8%; Figure VII -I in the online-only Data Supplement), we found a striking increase in mature Bmi1-derived endothelial cells (up to 6-fold; Figure 6C) De novo formation of microvessels is essential for longterm ventricular remodeling after AMI. 41 To evaluate this angiogenic response, we used FACS to quantify in vivo endothelial cell dynamics. Three days after AMI, endothelial cells decreased acutely, probably because of the ischemic process. Revascularization began several days after infarction and was complete at 2 months after AMI ( Figure 6D ). To analyze the dynamic of Bmi1 + cardiac progenitor cells during this revascularization, we also used FACS to trace Bmi1-derived cells from Bmi1
CreERT/+ R26 YFP/+ mice. We confirmed a significant contribution of these cells to the angiogenic response, which was especially notable from 2 weeks to 2 months after AMI ( Figure 6E ). Histological analysis showed Bmi1-derived endothelial cells in infarcted and remote areas, contributing to arterioles in the myocardium and to veins in the subepicardium ( Figure 6C and 6F) . The results suggest that at 4 months after damage, Bmi1
+ progenitor cells are a relevant source of cardiac endothelial cells, and contribute up to 20% of total endothelial cells in the infarcted heart.
Discussion
Although knowledge of the effect of gene mutations in cardiac disease development is growing rapidly, 5 the role of distinct adult cardiac progenitor cell populations after AMI remains poorly understood. Here, we show that after AMI, murine cardiac progenitor-like Sca1 +
Bmi1
+ cells 16, 47 are necessary for the angiogenic response and that their absence induces ischemicdilated cardiac phenotype.
Polycomb-related BMI1 protein is necessary for the maintenance of several adult stem cell populations, mainly through its capacity to inhibit senescence-related genes and to regulate mitochondrial function. 48, 49 In-depth analysis of how BMI1 acts has nonetheless allowed description of specific tissuerelated functions. In mesenchymal cells, BMI1 inhibits the expression of key chemokines from the senescence-associated secretory phenotype. 50 In muscle satellite cells, BMI1 enhances progenitor cell protection through metallothionein 1 upregulation. 51 In the heart, recent observations indicate that BMI1 represses a cardiogenic differentiation program, 52, 53 thus identifying cardiac progenitor-like cells. 16 In the majority of tissues, however, high BMI1 expression defines a mixture of progenitor cells and in some cases, Bmi1 + cells are not essential for tissue homeostasis. [54] [55] [56] The characteristics and physiological role of Bmi1 + progenitor cells in the adult heart remain unexplored.
Our results showed that in murine adult heart, Bmi1 + cells are a Sca1 + heterogeneous mixture of endothelial-and mesenchymal-related nonmyocyte cells. Expression of the endothelial-related CD31 protein in progenitor cells is not uncommon, as endothelial and progenitor cells are linked in several organs during development, and even in adulthood. 33, 57, 58 Proliferation capacity, the mRNA expression profile, and the matrigel angiogenesis assay clearly indicated that cardiac Bmi1 + cells are not mature endothelial cells. An in vivo differentiation assay with a very low dose of Tx showed that, after chase, the majority of Bmi1-derived cell groups were composed of only 1 or 2 mature cell types. The absence of a direct relationship between group size and a number of cardiac cell types might be explained by the more rapid proliferation of endothelial and myofibroblast cells compared with cardiomyocytes, 59 or by short-term progenitor identity of the majority of Bmi1 + cells. Because most studies describe limited multipotency in adult cardiac progenitor cells, 11, 36 it is possible that like other transcription factors, BMI1 expression defines a progenitorlike state of several cell populations in the heart. 60, 61 In the human heart, BMI1 measurement suggests that c-Kit + cardiac stem cells 10 are not the main BMI1 source, whose identification requires additional study.
To evaluate the functional importance of Sca1 + Bmi1 + cells in murine hearts, we used a conditional Cre-mediated cell ablation system. 23 The Rosa26 DTA allele allowed highefficiency removal of Bmi1 + cells labeled in the Rosa26 YFP reporter allele (≈3% of nonmyocyte cells). CRE deletion efficiency was analogous in both Rosa26 alleles, probably because of the similar size of the deletion fragments and locus accessibility. 62 One strength of this DTA cellular ablation system is that it allows analysis of cardiac cell dynamics in Bmi1 + cell-deficient hearts considering cardiac cell plasticity; 45 we thus provide a physiological description of the importance of Bmi1 + cardiac progenitor cells. In contrast to our prediction, Bmi1-progenitor cell ablation in homeostasis did not affect cardiac function or mouse lifespan. In homeostasis, BMI1 expression levels were recovered after several months, accompanied by a relative increase in the contribution of Bmi1 + cells that escaped ablation to cardiac cell progeny, suggesting cardiac cell plasticity. 45 The low adult cardiac cell turnover 59 together with the permissive environment for cell plasticity in homeostasis, and the lack of ischemia-mediated cell activation of Bmi1 + cardiac progenitors 47 may explain the absence of cardiac dysfunction in Bmi1 + cell-deficient hearts in homeostasis. Echocardiography and histological analyses showed that after AMI, nonetheless, Bmi1 + cardiac progenitor cells became necessary for correct ventricular remodeling and cardiac function. After infarction, the loss of cardiomyocytes and vasculature, accompanied by formation of a fibrotic scar, induces cardiac remodeling. 2 In some cases, however, ischemic damage evolves to eccentric hypertrophy (ischemicdilated phenotype), characterized by an enlarged LV chamber and thinning of the interventricular septum, in which myocytes typically lengthen; these factors lead to reduced cardiac function. 63 Histological analysis at 4 months after AMI showed that Bmi1 + cell-deficient hearts developed eccentric hypertrophy compared with control hearts. The cellular cause of this pathological remodeling was probably deficient angiogenesis and increased scar size. The absence of increased fibrosis and the fact that disruption of the angiogenic process can increase scar size [64] [65] [66] nonetheless suggest that the cardiac phenotype in Bmi1 + cell-deficient hearts is closely linked to impaired injury-induced angiogenesis.
Endothelial cell subpopulations are able to differentiate into cardiomyocytes, pericytes, and fibroblasts in the adult mouse heart. [30] [31] [32] Although endothelial cells make up the cardiac population with highest cell turnover, 59 the source of these cells in adult mice is not clear. Several authors describe an important role for BM-derived circulating endothelial progenitor cells. 67 The mesenchymalto-endothelial transition is also reported to contribute to substantial numbers of endothelial cells after AMI; 68 a recent study using several genetic-tracing studies nonetheless challenged these conclusions and suggests that only preexisting endothelial cells and endothelial-related progenitor cells contribute to neovascularization after injury. 69 Our results showed that Sca1 + Bmi1 + cells are a relevant population during postdamage angiogenesis, and 2 months after AMI contribute up to 20% of total cardiac endothelial cells. 
